# OnCo record yechezkel-barenholz (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/yechezkel-barenholz/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "yechezkel-barenholz" ;
  schema:name "Yechezkel Barenholz"@en ;
  schema:description "Invented the chemistry that made Doxil work, the first nanomedicine any regulator approved, which is still a standard treatment for relapsed ovarian cancer three decades later."@en ;
  schema:url <https://onco.cc/people/yechezkel-barenholz/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://medicine.ekmd.huji.ac.il/en/research/yechezkelb/Pages/default.aspx>, <https://pubmed.ncbi.nlm.nih.gov/?term=Barenholz%20Y%5BAuthor%5D%20liposome> ;
  onco:tag "scientist", "drug-delivery" ;
  schema:jobTitle "Professor, Laboratory of Membrane and Liposome Research, Hebrew University-Hadassah Medical School" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/kaposi-sarcoma/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/pegylated-liposomal-doxorubicin/>, <https://onco.cc/drugs/doxorubicin/> ;
  onco:institutions <https://onco.cc/institutions/hebrew-university-of-jerusalem/>, <https://onco.cc/institutions/hadassah/> ;
  schema:affiliation <https://onco.cc/institutions/hebrew-university-of-jerusalem/> .